Variant report

Variant	nsv964088
Chromosome Location	chr4:119510579-119514502
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:551)
CpG islands
(count:61)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:551 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:119512536-119512865	K562	blood:	n/a	n/a
2	ARID3A	chr4:119512561-119512966	HepG2	liver:	n/a	n/a
3	ATF1	chr4:119512070-119513121	K562	blood:	n/a	n/a
4	ATF2	chr4:119512614-119513118	H1-hESC	embryonic stem cell:	n/a	chr4:119512938-119512949
5	ATF2	chr4:119512592-119513106	H1-hESC	embryonic stem cell:	n/a	chr4:119512938-119512949
6	ATF2	chr4:119512613-119513089	GM12878	blood:	n/a	chr4:119512938-119512949
7	ATF2	chr4:119512454-119513054	GM12878	blood:	n/a	chr4:119512938-119512949
8	ATF3	chr4:119512712-119513009	HepG2	liver:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
9	ATF3	chr4:119512604-119513031	HepG2	liver:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
10	ATF3	chr4:119512726-119513024	GM12878	blood:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
11	ATF3	chr4:119512508-119513020	K562	blood:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
12	ATF3	chr4:119512767-119512947	GM12878	blood:	n/a	n/a
13	ATF3	chr4:119512715-119513024	K562	blood:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
14	ATF3	chr4:119512562-119513118	H1-hESC	embryonic stem cell:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
15	ATF3	chr4:119512622-119513034	H1-hESC	embryonic stem cell:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
16	ATF3	chr4:119512720-119513004	K562	blood:	n/a	chr4:119512939-119512959 chr4:119512938-119512951
17	BACH1	chr4:119512429-119512706	K562	blood:	n/a	n/a
18	BATF	chr4:119512730-119513339	GM12878	blood:	n/a	n/a
19	BCL11A	chr4:119512789-119513378	GM12878	blood:	n/a	n/a
20	BHLHE40	chr4:119512396-119513016	K562	blood:	n/a	n/a
21	BHLHE40	chr4:119512528-119512917	GM12878	blood:	n/a	n/a
22	BRCA1	chr4:119512677-119513029	GM12878	blood:	n/a	n/a
23	BRCA1	chr4:119512486-119513039	HepG2	liver:	n/a	n/a
24	BRCA1	chr4:119512666-119513025	H1-hESC	embryonic stem cell:	n/a	n/a
25	BRCA1	chr4:119512297-119513077	Hela-S3	cervix:	n/a	n/a
26	CBX3	chr4:119512471-119513394	K562	blood:	n/a	n/a
27	CBX3	chr4:119512472-119513060	K562	blood:	n/a	n/a
28	CCNT2	chr4:119512727-119513012	K562	blood:	n/a	n/a
29	CEBPB	chr4:119512545-119513304	K562	blood:	n/a	n/a
30	CEBPB	chr4:119512544-119513304	A549	lung:	n/a	n/a
31	CEBPB	chr4:119512539-119513232	HepG2	liver:	n/a	n/a
32	CEBPB	chr4:119512499-119513354	K562	blood:	n/a	n/a
33	CEBPD	chr4:119512803-119513297	K562	blood:	n/a	n/a
34	CEBPD	chr4:119512767-119513133	HepG2	liver:	n/a	n/a
35	CHD1	chr4:119512605-119512972	GM12878	blood:	n/a	n/a
36	CHD2	chr4:119512676-119513021	K562	blood:	n/a	n/a
37	CHD2	chr4:119512696-119513056	H1-hESC	embryonic stem cell:	n/a	n/a
38	CHD2	chr4:119512645-119513027	Hela-S3	cervix:	n/a	n/a
39	CHD2	chr4:119512482-119513011	GM12878	blood:	n/a	n/a
40	CREB1	chr4:119512474-119513146	GM12878	blood:	n/a	n/a
41	CREB1	chr4:119512379-119513121	HepG2	liver:	n/a	n/a
42	CREB1	chr4:119512583-119513141	H1-hESC	embryonic stem cell:	n/a	n/a
43	CREB1	chr4:119512490-119513011	ECC-1	luminal epithelium:	n/a	n/a
44	CREB1	chr4:119512547-119513147	K562	blood:	n/a	n/a
45	CREB1	chr4:119512455-119513089	A549	lung:	n/a	n/a
46	CREB1	chr4:119512335-119513168	K562	blood:	n/a	n/a
47	CREB1	chr4:119512419-119513010	HepG2	liver:	n/a	n/a
48	CREB1	chr4:119512450-119513021	GM12878	blood:	n/a	n/a
49	CREB1	chr4:119512481-119513129	ECC-1	luminal epithelium:	n/a	n/a
50	CREB1	chr4:119512533-119513184	A549	lung:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:119512985-119513035	SK-N-SH_RA	brain:	n/a
2	chr4:119512985-119513035	ovcar-3	ovarian:	n/a
3	chr4:119512985-119513035	HL-60	blood:	n/a
4	chr4:119512985-119513035	BJ	skin:	n/a
5	chr4:119512985-119513035	HPAEpiC	pulmonary alveolar:	n/a
6	chr4:119512985-119513035	PANC-1	pancreas:	n/a
7	chr4:119512985-119513035	NB4	blood:	n/a
8	chr4:119512985-119513035	GM12891	blood:	n/a
9	chr4:119512985-119513035	Hela-S3	cervix:	n/a
10	chr4:119512985-119513035	GM06990	blood:	n/a
11	chr4:119512985-119513035	LNCaP	prostate:	n/a
12	chr4:119512985-119513035	BE2_C	brain:	n/a
13	chr4:119512985-119513035	Jurkat	blood:	n/a
14	chr4:119512985-119513035	NHDF-neo	bronchial:	n/a
15	chr4:119512985-119513035	K562	blood:	n/a
16	chr4:119512985-119513035	NHBE	bronchial:	n/a
17	chr4:119512985-119513035	AG04450	lung:	fetal
18	chr4:119512985-119513035	PFSK-1	brain:	n/a
19	chr4:119512985-119513035	GM19239	blood:	n/a
20	chr4:119512985-119513035	SK-N-MC	brain:	n/a
21	chr4:119512985-119513035	HRPEpiC	eye:	n/a
22	chr4:119512985-119513035	HAEpiC	amniotic membrane:	n/a
23	chr4:119512985-119513035	HUVEC	blood vessel:	n/a
24	chr4:119512985-119513035	HIPEpiC	eye:	n/a
25	chr4:119512985-119513035	Hepatocyte	liver:	n/a
26	chr4:119512985-119513035	RPTEC	kidney:	n/a
27	chr4:119512985-119513035	AoSMC	blood vessel:	n/a
28	chr4:119512985-119513035	H1-hESC	embryonic stem cell:	embryo
29	chr4:119512985-119513035	ProgFib	skin:	n/a
30	chr4:119512985-119513035	SK-N-SH	brain:	n/a
31	chr4:119512985-119513035	GM12892	blood:	n/a
32	chr4:119512985-119513035	T-47D	breast:	n/a
33	chr4:119512985-119513035	SAEC	small airway:	n/a
34	chr4:119512985-119513035	PrEC	prostate:	n/a
35	chr4:119512985-119513035	GM12878	blood:	n/a
36	chr4:119512985-119513035	HMEC	breast:	n/a
37	chr4:119512985-119513035	HEK293	kidney:	embryo
38	chr4:119512985-119513035	HCF	heart:	n/a
39	chr4:119512985-119513035	HCPEpiC	choroid plexus:	n/a
40	chr4:119512985-119513035	HCM	heart:	n/a
41	chr4:119512985-119513035	HRE	kidney:	n/a
42	chr4:119512985-119513035	NH-A	brain:	n/a
43	chr4:119512985-119513035	AG04449	skin:	fetal
44	chr4:119512985-119513035	Caco-2	colon:	n/a
45	chr4:119512985-119513035	ECC-1	luminal epithelium:	n/a
46	chr4:119512985-119513035	AG09309	skin:	n/a
47	chr4:119512985-119513035	HNPCEpiC	eye:	n/a
48	chr4:119512985-119513035	AG09319	gingival:	n/a
49	chr4:119512985-119513035	HepG2	liver:	n/a
50	chr4:119512985-119513035	SKMC	muscle:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:119508532..119510926-chr4:119602289..119604089,2	MCF-7	breast:
2	chr4:119503145..119504877-chr4:119508741..119511511,2	K562	blood:
3	chr4:119505891..119507633-chr4:119509359..119512309,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000260404	TF binding region
ENSG00000260404	CpG island

Extended variants
information (count: 186 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:186 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs549093767	chr4:119510632-119510633	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs569562261	chr4:119510681-119510682	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs181423342	chr4:119510705-119510706	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs535155606	chr4:119510723-119510724	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs554637694	chr4:119510726-119510727	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs141664880	chr4:119510787-119510788	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs375228514	chr4:119510800-119510801	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs186918688	chr4:119510828-119510829	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs145920234	chr4:119510872-119510873	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs190162744	chr4:119510968-119510969	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs535465899	chr4:119510969-119510970	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs550476484	chr4:119510973-119510974	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs575540155	chr4:119510979-119510980	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs568695647	chr4:119510990-119510991	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs563946935	chr4:119510993-119510994	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs10022024	chr4:119511022-119511023	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs540349597	chr4:119511029-119511030	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs560247622	chr4:119511035-119511036	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs557238469	chr4:119511036-119511037	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs529347151	chr4:119511061-119511062	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs549405322	chr4:119511081-119511082	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs562732004	chr4:119511131-119511132	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs532043307	chr4:119511140-119511141	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs10857060	chr4:119511163-119511164	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs546149729	chr4:119511186-119511187	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs141333234	chr4:119511207-119511208	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs556520149	chr4:119511227-119511228	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs547991789	chr4:119511233-119511234	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs181927395	chr4:119511234-119511235	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs7349675	chr4:119511318-119511319	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs112536874	chr4:119511400-119511401	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs376308751	chr4:119511404-119511405	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs186088919	chr4:119511449-119511450	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs575088142	chr4:119511450-119511451	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs538144893	chr4:119511455-119511456	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs190950405	chr4:119511460-119511461	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs577431471	chr4:119511516-119511517	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs528661708	chr4:119511553-119511554	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs371665294	chr4:119511646-119511647	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs182107488	chr4:119511657-119511658	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs150387126	chr4:119511663-119511664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs542713960	chr4:119511664-119511665	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs562901879	chr4:119511708-119511709	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs137902640	chr4:119511716-119511717	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs560918159	chr4:119511725-119511726	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs149446828	chr4:119511759-119511760	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs565608226	chr4:119511821-119511822	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs368064412	chr4:119511850-119511851	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs145944320	chr4:119511883-119511884	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs185183574	chr4:119511933-119511934	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	16272173	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18194544	CNVD
Autism	19246517	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:376 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:119506600-119512800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr4:119507200-119512400	Weak transcription	Hela-S3	cervix
3	chr4:119507200-119512600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr4:119507400-119512200	Weak transcription	Stomach Mucosa	stomach
5	chr4:119507400-119512400	Weak transcription	HUES64 Cell Line	embryonic stem cell
6	chr4:119507800-119512000	Weak transcription	Left Ventricle	heart
7	chr4:119507800-119513200	Weak transcription	Spleen	Spleen
8	chr4:119508000-119512000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
9	chr4:119508000-119512000	Weak transcription	Pancreas	Pancrea
10	chr4:119508000-119512000	Weak transcription	Skeletal Muscle Female	skeletal muscle
11	chr4:119508000-119512200	Weak transcription	K562	blood
12	chr4:119508000-119512400	Weak transcription	HUES6 Cell Line	embryonic stem cell
13	chr4:119508000-119512400	Weak transcription	Fetal Muscle Trunk	muscle
14	chr4:119508000-119512400	Weak transcription	Ovary	ovary
15	chr4:119508000-119512600	Weak transcription	HSMM	muscle
16	chr4:119508200-119512400	Weak transcription	Skeletal Muscle Male	skeletal muscle
17	chr4:119508600-119512000	Weak transcription	Adipose Nuclei	Adipose
18	chr4:119508800-119511800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr4:119508800-119512400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr4:119509000-119512400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
21	chr4:119509400-119512200	Weak transcription	Liver	Liver
22	chr4:119510400-119510800	Enhancers	Monocytes-CD14+_RO01746	blood
23	chr4:119510400-119512400	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr4:119510800-119511000	Enhancers	Gastric	stomach
25	chr4:119510800-119511400	Weak transcription	Brain Substantia Nigra	brain
26	chr4:119510800-119511600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
27	chr4:119511000-119512800	Weak transcription	Gastric	stomach
28	chr4:119511400-119512400	Enhancers	Brain Substantia Nigra	brain
29	chr4:119511600-119512000	Enhancers	Monocytes-CD14+_RO01746	blood
30	chr4:119511600-119512400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
31	chr4:119511800-119512200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
32	chr4:119511800-119512400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr4:119512000-119512200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
34	chr4:119512000-119512200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
35	chr4:119512000-119512200	Enhancers	Primary T helper naive cells from peripheral blood	blood
36	chr4:119512000-119512200	Enhancers	Primary T helper cells PMA-I stimulated	--
37	chr4:119512000-119512200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
38	chr4:119512000-119512200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr4:119512000-119512200	Enhancers	Adipose Nuclei	Adipose
40	chr4:119512000-119512200	Enhancers	Dnd41	blood
41	chr4:119512000-119512400	Enhancers	iPS-15b Cell Line	embryonic stem cell
42	chr4:119512000-119512400	Enhancers	Primary B cells from peripheral blood	blood
43	chr4:119512000-119512400	Enhancers	Primary T cells fromperipheralblood	blood
44	chr4:119512000-119512400	Enhancers	Primary hematopoietic stem cells	blood
45	chr4:119512000-119512400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
46	chr4:119512000-119512400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
47	chr4:119512000-119512400	Enhancers	Primary T killer memory cells from peripheral blood	blood
48	chr4:119512000-119512400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr4:119512000-119512400	Enhancers	Fetal Intestine Large	intestine
50	chr4:119512000-119512400	Enhancers	Left Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links